$SPEV
SHOREPOWER TECHNOLOGIES INC. Stock $spev

$spev Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224023724 Filed on June 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$34.52K	$1.170K	$19.61K
YoY Change	235.18%
Cost Of Revenue	$24.67K	$21.74K	$49.38K
YoY Change	126.62%		13.13%
Gross Profit	$9.850K	-$20.57K	-$35.68K
YoY Change	-1778.02%		53.48%
Gross Profit Margin	28.53%	-1758.12%	-181.93%
Selling, General & Admin	$135.1K	$83.12K	$548.6K
YoY Change	35.06%	-68.03%	-8.57%
% of Gross Profit	1371.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$135.1K	$83.12K	$548.6K
YoY Change	37.2%	-68.03%	-8.16%
Operating Profit	-$125.2K	-$103.7K	-$584.2K
YoY Change	26.44%		-2.19%
Interest Expense	-$23.66K	-$27.28K	-$77.79K
YoY Change	-101.39%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	-$77.73K
YoY Change	-100.0%
Pretax Income	-$148.9K	-$131.0K	-$662.0K
YoY Change	24.06%	-49.63%	10.33%
Income Tax
% Of Pretax Income
Net Earnings	-$148.9K	-$131.0K	-$662.0K
YoY Change	29.36%	-49.63%	10.83%
Net Earnings / Revenue	-431.26%	-11194.02%	-3375.65%
Basic Earnings Per Share			-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	48.48M shares	48.48M shares	48.14M shares
Diluted Shares Outstanding			48.14M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.46K	$177.1K	$177.1K
YoY Change	-90.1%	60.99%	60.99%
Cash & Equivalents		$0.00
Short-Term Investments
Other Short-Term Assets	$5.750K	$8.930K	$8.930K
YoY Change	-42.5%	-98.38%	-98.38%
Inventory	$18.22K	$7.359K	$7.360K
Prepaid Expenses		$8.932K
Receivables	$14.39K
Other Receivables	$0.00
Total Short-Term Assets	$89.82K	$208.4K	$208.4K
YoY Change	-83.41%	-69.14%	-69.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.000K	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$1.000K	$1.000K	$1.000K
YoY Change	0.0%	0.0%
TOTAL ASSETS
Total Short-Term Assets	$89.82K	$208.4K	$208.4K
Total Long-Term Assets	$1.000K	$1.000K	$1.000K
Total Assets	$90.82K	$209.4K	$209.4K
YoY Change	-83.25%	-69.24%	-69.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.58K	$54.99K	$54.99K
YoY Change	-33.46%	-50.01%	-50.01%
Accrued Expenses	$323.1K	$232.7K	$232.7K
YoY Change	361.51%	1063.65%	1063.65%
Deferred Revenue
YoY Change
Short-Term Debt	$111.4K	$111.4K	$111.4K
YoY Change	-7.17%	1.27%	1.27%
Long-Term Debt Due	$125.8K	$125.8K	$125.8K
YoY Change	14.34%	14.34%	14.34%
Total Short-Term Liabilities	$606.8K	$524.9K	$524.9K
YoY Change	66.84%	3805.48%	54.38%
LONG-TERM LIABILITIES
Long-Term Debt	$943.5K	$995.1K	$995.1K
YoY Change	-17.95%	-15.67%	-15.67%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$943.5K	$995.1K	$995.1K
YoY Change	-17.95%	-15.67%	-15.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$606.8K	$524.9K	$524.9K
Total Long-Term Liabilities	$943.5K	$995.1K	$995.1K
Total Liabilities	$1.550M	$1.520M	$1.520M
YoY Change	2.74%	11209.68%	-0.65%
SHAREHOLDERS EQUITY
Retained Earnings		-$2.576M
YoY Change		-66.94%
Common Stock		$484.8K
YoY Change		2.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.460M	-$1.311M	-$1.311M
YoY Change
Total Liabilities & Shareholders Equity	$90.82K	$209.4K	$209.4K
YoY Change	-83.25%	-69.24%	-69.21%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$148.9K	-$131.0K	-$662.0K
YoY Change	29.36%	-49.63%	10.83%
Depreciation, Depletion And Amortization			$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$74.02K	-$63.21K	-$341.6K
YoY Change	-39.3%	-42.54%	112.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-51.60K	-37.80K	-$149.2K
YoY Change	84.29%	-105.73%	-122.6%
NET CHANGE
Cash From Operating Activities	-74.02K	-63.21K	-$341.6K
Cash From Investing Activities
Cash From Financing Activities	-51.60K	-37.80K	-$149.2K
Net Change In Cash	-125.6K	-101.0K	-$490.8K
YoY Change	-16.23%	-120.2%	-209.22%
FREE CASH FLOW
Cash From Operating Activities	-$74.02K	-$63.21K	-$341.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000764630
CY2024Q1	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2024	SPEV	Adjustment For Reverse Merger AdjustmentForReverseMerger		usd
CY2024	us-gaap	Depreciation Depreciation		usd
CY2023	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent		usd
CY2023	SPEV	Increase Decrease In Accrued Interest Related Party IncreaseDecreaseInAccruedInterestRelatedParty		usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q1	SPEV	Funds Held In Escrow FundsHeldInEscrow		usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024	us-gaap	Stock Issued1 StockIssued1		usd
CY2024	SPEV	Common Stock Issued For Services Prior To Reverse Merger Related Party CommonStockIssuedForServicesPriorToReverseMergerRelatedParty		usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	SPEV	Income Tax Reconciliation Related Party Accurals IncomeTaxReconciliationRelatedPartyAccurals		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-02-29
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-29
CY2024	dei	Security12g Title Security12gTitle	Common Stock, $.01 par value
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	4253895	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48478678	shares
CY2024	dei	Auditor Firm AuditorFirmId	6631
CY2024	dei	Auditor Name AuditorName	Qi CPA LLC
CY2024	dei	Auditor Location AuditorLocation	Valley Stream, New York
CY2023Q1	us-gaap	Cash Cash	114851	usd
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	553000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8932	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	535	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6880	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	675266	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1000	usd
CY2023Q1	us-gaap	Assets Assets	676266	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	106394	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	358422	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1522787	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6894356	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6894356	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48478678	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48478678	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47435106	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47435106	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	474351	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	615284	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1913702	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	39975	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	39975	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	42454	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-846521	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	676266	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19610	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22281	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	49380	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	43648	usd
CY2024	SPEV	Revenue Share Expense RevenueShareExpense	5906	usd
CY2023	SPEV	Revenue Share Expense RevenueShareExpense	1877	usd
CY2024	us-gaap	Gross Profit GrossProfit	-35676	usd
CY2023	us-gaap	Gross Profit GrossProfit	-23244	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	273067	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	27249	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104594	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47481	usd
CY2024	SPEV	Consulting Expenses ConsultingExpenses	50903	usd
CY2023	SPEV	Consulting Expenses ConsultingExpenses	15750	usd
CY2024	us-gaap	Officers Compensation OfficersCompensation	120000	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	144800	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	548564	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	235280	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-584240	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-258524	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	65	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4031	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	77790	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	14968	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	46063	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-77725	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-57000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-661965	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-315524	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48138445	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48138445	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47133596	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47133596	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1595997	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	67500	usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	135000	usd
CY2023	SPEV	Stock Issued During Period Value Issued For Services Related Party StockIssuedDuringPeriodValueIssuedForServicesRelatedParty	135000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	67500	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	660000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-315524	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-846521	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-846521	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	198844	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-661965	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1310642	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1310642	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-661965	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-315524	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	46063	usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	197844	usd
CY2023	SPEV	Adjustment For Reverse Merger AdjustmentForReverseMerger	189911	usd
CY2023	us-gaap	Depreciation Depreciation	5133	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	479	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2611	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8397	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-31673	usd
CY2024	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	15000	usd
CY2024	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-51400	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-22955	usd
CY2024	SPEV	Increase Decrease In Accrued Interest Related Party IncreaseDecreaseInAccruedInterestRelatedParty	77790	usd
CY2024	SPEV	Increase Decrease In Accrued Officer Compensation IncreaseDecreaseInAccruedOfficerCompensation	120000	usd
CY2023	SPEV	Increase Decrease In Accrued Officer Compensation IncreaseDecreaseInAccruedOfficerCompensation	144800	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-341607	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-303332	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	660000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7240	usd
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	149156	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1557	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-149156	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	651203	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-490763	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	347871	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	114851	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	319980	usd
CY2023Q1	SPEV	Funds Held In Escrow FundsHeldInEscrow	553000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	177088	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	667851	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	337500	usd
CY2023	SPEV	Common Stock Issued For Services Prior To Reverse Merger Related Party CommonStockIssuedForServicesPriorToReverseMergerRelatedParty	67500	usd
CY2024	SPEV	Adjustment To Additional Paid In Capital Merger Transaction AdjustmentToAdditionalPaidInCapitalMergerTransaction	5872000	usd
CY2024Q1	us-gaap	Grants Receivable GrantsReceivable	16000000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_z5a5r2nHseqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_z8193FUemOw4">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_ziv6DqkCjDme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_z6vzp2UmLvX4">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	7359	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6880	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2575667	usd
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	15000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.06
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	660000	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	553000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1043572	shares
CY2023Q3	us-gaap	Share Price SharePrice	0.19
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	198279	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48478678	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47435106	shares
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.06
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	660000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2023Q1	us-gaap	Class Of Warrant Or Right Expense Or Revenue Recognized ClassOfWarrantOrRightExpenseOrRevenueRecognized	The warrants are callable by the Company if its common stock trades at $0.75 for at least 20 trading days and at a volume of not less than 30,000 shares per day.
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	524737	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	409300	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	345100	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	409300	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	345100	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-139000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-125400	usd
CY2024	SPEV	Income Tax Reconciliation Related Party Accurals IncomeTaxReconciliationRelatedPartyAccurals	5200	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	41500	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	85100	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	92300	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	40300	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1574000	usd

Files In Submission

Name	View Source	Status
0001493152-24-023724-index-headers.html	Edgar Link	pending
0001493152-24-023724-index.html	Edgar Link	pending
0001493152-24-023724.txt	Edgar Link	pending
0001493152-24-023724-xbrl.zip	Edgar Link	pending
ex14-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spev-20240229.xsd	Edgar Link	pending
spev-20240229_lab.xml	Edgar Link	unprocessable
spev-20240229_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
spev-20240229_cal.xml	Edgar Link	unprocessable
spev-20240229_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPEV
SHOREPOWER TECHNOLOGIES INC. Stock $spev

2024 Q2 Form 10-K Financial Statement

#000149315224023724 Filed on June 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPEV SHOREPOWER TECHNOLOGIES INC. Stock $spev

2024 Q2 Form 10-K Financial Statement

#000149315224023724 Filed on June 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPEV
SHOREPOWER TECHNOLOGIES INC. Stock $spev